A questionnaire-based study on knowledge and attitude towards counterfeit medication among the doctors in tertiary care hospital

Authors

  • Vijay Yadav Department of Pharmacology, Prasad Institute of Medical Science, Lucknow, Uttar Pradesh, India
  • Navin Budania Department of Pharmacology, S.H.K.M. Government Medical College, Nuh, Haryana 122107, India
  • Arka Mondal Department of Pharmacology, S.H.K.M. Government Medical College, Nuh, Haryana 122107, India
  • Naveen Kumar Department of Pharmacology, S.H.K.M. Government Medical College, Nuh, Haryana 122107, India
  • Ritesh Kumar Department of Pharmacology, S.H.K.M. Government Medical College, Nuh, Haryana 122107, India
  • Vinod Kumar Bhardwaj Department of Pharmacology, S.H.K.M. Government Medical College, Nuh, Haryana 122107, India
  • Vijay Kumar Chhockra Department of Pharmacology, S.H.K.M. Government Medical College, Nuh, Haryana 122107, India
  • Nadish Garg Department of Pharmacology, S.H.K.M. Government Medical College, Nuh, Haryana 122107, India
  • Aditi Punia Department of Pharmacology, S.H.K.M. Government Medical College, Nuh, Haryana 122107, India
  • Priyamvada Sharma Department of Pharmacology, F.H. Medical College & Hospital, Uttar Pradesh, India

DOI:

https://doi.org/10.18203/2319-2003.ijbcp20181190

Keywords:

Counterfeit drug, Doctors, Medication

Abstract

Background: Counterfeit drugs are a global problem and suffered almost all developing and developed countries worldwide. In India, it is a major problem which results life threatening issues as well as financial loss on health system. So, we conducted a cross sectional questionnaire-based study on knowledge and exposure to counterfeit drugs of doctors at SHKM Govt. Medical College, Nuh, Haryana, India.

Methods: A structured questionnaire was distributed to 100 registered doctors. The questionnaire was based on knowledge, attitude and its consequence on the heath system by the practices of counterfeit medication.

Results: There were Twenty questionnaires excluded from the study due to incomplete information. Only 57.77% (46/80) subjects having the knowledge of questionnaire correct meaning of counterfeit drug. However, almost 90% (72/80) subjects were aware about its dangerous effects. More than 50% of the subjects have suggested that modern technology is capable to control counterfeiting of the medicine.

Conclusions: Counterfeit drugs create a people health hazard and waste to consumer income. The proper knowledge, awareness and modern technological approaches are the devices may helpful in diminution of counterfeit medication practices.

 

References

Geneva, Switzerland: Department of Essential Drugs and Other Medicines, WHO; 1999. World Health Organization. Counterfeit Drugs: Guidelines for the Development of Measures to Combat Counterfeit Drugs. Available at: http://whqlibdoc.who.int/hq/1999/WHO_EDM_QSM99.1.pdf .

World Health Organization. General Information on Counterfeit Medicines. [Last accessed on 2013 May 19]. Available at: http://www.who.int/medicines/services/counterfeit/overview/en

Counterfeit Drugs Kill, World Health Organization. Available at: http://www.who.int/impact/FinalBrochureWHA2008a.pdf

Bate R. Washington DC. American Enterprise Institute. Making a killing. The deadly implications of the counterfeit drug trade; 2008.

Sammons HM, Choonara I. Substandard medicines: a greater problem than counterfeit medicines? BMJ Paediatrics Open. 2017;1:e000007.

Shah NA, Bhagya M, Sattigeri, Nirav NP, Haresh AD. Counterfeit drugs in India: significance and impact on pharmacovigilance. Int J Res Med Sci. 2015;3:2156-60.

Chika FU, Alphonsus CO, Obiageli FE, Maureen NA, Andrew UU, Samuel OI. Factors associated with drug counterfeit in Nigeria: A twelve-year review. British Journal of Medicine & Medical Research. 2016;12:1-8.

Golocorbin KS, Mikov M. Counterfeit drugs as a gobal threat to health. Med Pregl. 2011;64:285-90.

Nagaraj A, Tambi S, Biswas G, Ganta S, Kumawat H, Mathur G. Counterfeit medication: Perception of doctors and medical wholesale distributors in western India. J Int Soc Prev Community Dent. 2015;5:S7-S11.

Mackey TK, Cuomo R, Guerra C, Liang BA. After counterfeit Avastin®--what have we learned and what can be done? Nat. Rev Clin Oncol. 2015;12(5):302-08.

Mackey TK, Liang BA. The global counterfeit drug trade: patient safety and public health risks. J Pharm. Sci. 2011;100:4571-79.

Bansal D, Malla S, Gudala K, Tiwari P. Anti-counterfeit technologies: a pharmaceutical industry perspective. Sci Pharm. 2013;81:1-13.

Almuzaini T, Choonara I, Sammons H. Substandard and counterfeit medicines: asystematic review of the literature. BMJ Open. 2013;3;1-7.

Downloads

Published

2018-03-23

How to Cite

Yadav, V., Budania, N., Mondal, A., Kumar, N., Kumar, R., Kumar Bhardwaj, V., Kumar Chhockra, V., Garg, N., Punia, A., & Sharma, P. (2018). A questionnaire-based study on knowledge and attitude towards counterfeit medication among the doctors in tertiary care hospital. International Journal of Basic & Clinical Pharmacology, 7(4), 802–806. https://doi.org/10.18203/2319-2003.ijbcp20181190

Issue

Section

Original Research Articles